Arylamine N-acetyltransferases (NATs) are polymorphic xenobiotic metabolising enzymes, linked to cancer susceptibility in a variety of tissues. In humans and in mice there are multiple NAT isoforms. To identify whether the different isoforms represent inbuilt redundancy or whether they have unique roles, we have generated mice with a null allele of Nat2 by gene targeting. This mouse line conclusively demonstrates that the different isoforms have distinct functions with no compensatory expression in the Nat2 null animals of the other isoforms. In addition, we have used the transgenic line to show the pattern of Nat2 expression during development. Although Nat2 is not essential for embryonic development, it has a widespread tissue distribution from at least embryonic day 9.5. This mouse line now paves the way for the teratological role of Nat2 to be tested.
INTRODUCTION
Arylamine N-acetyltransferases (NATs) are polymorphic xenobiotic metabolising enzymes able to catalyse the acetylation of arylamine, hydrazine or arylhydroxylamine substrates using acetyl CoA as a cosubstrate. 1, 2 Polymorphisms at the NAT loci have been linked to susceptibility to a variety of different cancers, particularly in combination with exposure to carcinogenic arylamine or hydrazines, including cancer of the colon, 3 breast, 4 bladder 5 and larynx. 6 In humans there are two NAT isoforms with distinct but overlapping substrate specificities and tissue expression profiles, both of which exhibit interindividual variation in enzymic activity. 2 Human NAT2, expressed in liver and intestine, traditional sites for the expression of a drug metabolising enzyme, is responsible for the 'classical' polymorphic acetylation of the antitubercular drug isoniazid. 1, 7 Human NAT1 has a much broader tissue distribution and NAT1 activity has been detected in almost every location investigated including liver, intestine, erythrocytes, bladder and placenta. 2, 8 The developmental expression profiles of NAT1 and NAT2 also differ. NAT1 expression has been detected as early as the blastocyst stage, that is before the embryo has even implanted in the uterus, and NAT1 activity is at least 1000-fold greater than NAT2 activity in the placenta from 5.5 weeks of gestation. 9, 10 In human foetal tissue proper, NAT1-specific activity has been detected from 11 weeks gestation, the earliest reported investigation. 11 The early expression pattern and widespread tissue distribution of NAT1, combined with its ability to acetylate the folate catabolite paraaminobenzoylglutamate (p-abaglu), has aroused curiosity as to a possible endogenous role for NAT1 in folate metabolism, aside from its ability to metabolise xenobiotics. 10, 12, 13 In mice there are three Nat isoforms encoded at three loci, which have been located on chromosome 8. 14, 15 In humans there are also three NAT loci, but the third locus is a pseudogene 16 and, in terms of substrate specificity and expression profile, murine Nat2, despite the nomenclature, is the homologue of human NAT1. [17] [18] [19] Murine Nat2 transcripts have been detected in embryonic stem (ES) cells as well as embryonic tissue beginning at gestational day 10. 18, 20 Murine Nat2 expression has been detected, using antisera specific for murine Nat2, from embryonic day (E) 9.5 in developing neural, heart and gut tissue. 21 Murine Nat2 is active in the liver and kidneys from postnatal day 1 into adulthood as shown by acetylation of the isotypespecific substrate para-aminobenzoic acid (p-aba). 19 The expression of murine Nat1 is restricted to the liver and, in common with human NAT2, is able to metabolise isoniazid. [22] [23] [24] Murine Nat3 transcripts have been detected in spleen, but the activity of recombinant Nat3 towards common NAT substrates is either low or nonexistent. 17, 22, 25 The developmental expression profile, substrate specificity and tissue distribution of murine Nat2 make it a good model to study the in vivo role of human NAT1, both in terms of its ability to metabolise xenobiotics and its proposed role in folate metabolism. To investigate whether the different isoforms represent inbuilt redundancy or whether they have unique roles, we have generated mice deficient in Nat2 by creating a null (knockout) allele of Nat2 using homologous recombination in ES cells.
RESULTS

Generation of Mice with a Null Allele of Nat2
To create a null allele of the murine Nat2 gene, a targeting vector was designed to incorporate a TAG 3 /IRES/lacZ/loxP/ neo/loxP cassette 26 into the Nat2 coding region. A high frequency of neomycin-resistant colonies (45%) were identified to contain correctly targeted insertion (Figure 1) . Insertion of the cassette at this position was predicted to result in a nonfunctional C-terminal truncated gene product (truncated at nucleotide position 534), thus creating a null allele. Two independently derived targeted ES cell clones were used to generate chimeras that gave germline transmission of the targeted allele as determined by Southern blot and PCR (Figure 1) .
Initially, F1 heterozygotes for the Nat2*null allele (Nat2*+/ À) from the chimera test crosses (on both a C57Bl/6 and 129/Ola genetic background) were intercrossed to determine the viability of animals completely lacking Nat2. Nat2*null animals (Nat2*À/À) survive into adulthood and are apparently phenotypically normal on both the mixed 129/C57Bl/ 6 and pure 129/Ola genetic backgrounds. Anatomical normality was confirmed following a veterinary examination and Nat2*À/À animals have survived for longer than 15 months. F1 male heterozygotes were also backcrossed to C57Bl/6 and A/J strain mice and the lines were maintained by backcrossing heterozygotes at each generation. Fertility rates, Nat2 allelic inheritance and sex ratios were recorded from the backcrosses of Nat2 heterozygotes and intercrosses set up with heterozygotes derived from the backcrosses 1 and 2 with the A/J and C57Bl/6 strains, respectively (Table 1) . These parameters do not show any statistically significant differences from nontransgenic controls, indicating that the Nat2*null allele is inherited in a Mendelian fashion. In the case of live-born offspring from intercrosses (Nat2*+/À male Â Nat2*+/À female), however, the w 2 value of 10.49 for allelic inheritance approaches significance at the 5% level (for five degrees of freedom w 2 at 5% ¼ 11.07), indicating a marginal sex bias in the inheritance of the Nat2*null allele. This appears to be because of a slightly greater preponderance of Nat2*À/À females than predicted ( Table 1) .
Characterisation of Mice with a Null Allele of Nat2
To investigate the effect of a lack of Nat2 on total Nat activity, liver samples from six animals of each of the Nat2*+/+, Nat2*+/À and Nat2*À/À genotype were assayed for their acetylation ability. The NAT substrates p-aba and pabaglu, which are murine Nat2-specific substrates, 18, 19 and anisidine, which is acetylated by all three murine isozymes, 17, 22, 25 were used. Liver homogenates from all three genotypes demonstrated excellent genotype/phenotype correlation for p-aba and p-abaglu (Figure 2a and b) . Nat2*À/À mice were unable to acetylate p-aba or p-abaglu, even after overnight incubation with substrate at 371C (data not shown) and liver homogenates from Nat2*+/À mice had half the Nat2 activity of liver homogenates from Nat2*+/+ mice. When anisidine was used as substrate, Nat2*+/+, Nat2*+/À and Nat2*À/À liver homogenates had 100, 54.6 and 7.7% activity, respectively, of the specific activity of the pooled control wild-type samples.
Liver homogenates were subsequently tested for the presence of Nat protein using polyclonal antisera either specific for the Nat2 isozyme (antiserum 195) 21 or specific for all three murine Nat isozymes (antiserum 185) ( Figure 3 ). When equivalent amounts of total protein were loaded on an SDS-PAGE gel and immunoblotted with antiserum 195, no Nat2 reactive band could be detected in livers from Nat2*À/À animals, while livers from Nat2*+/À animals contained approximately half the Nat2 protein of their Nat2*+/+ littermates (Figure 3a) . Equivalent samples blotted with antiserum 185 showed a decrease in total Nat protein in Nat2*À/À and Nat2*+/À livers in comparison with their Nat2*+/+ littermates ( Figure 3b ).
Developmental Expression of Mouse Nat2
The reporter/ablation cassette (described previously 26 ) used to generate the knockout transgenic line contains the bacterial lacZ gene preceded by an IRES sequence. Consequently, this brings the expression of the lacZ gene in the targeted locus under the control of the Nat2 transcriptional regulatory elements. In order to investigate the developmental expression pattern of Nat2, Nat2*À/À and Nat2*+/À embryos (with +/+ embryos as controls) at embryonic days (E) 9.5, 11.5, 12.5 and 15.5 were stained with the chromogenic substrate X-gal. At all stages investigated, at a whole-mount level, Nat2 expression was ubiquitous because of expression in the skin. However, prior to E12.5, Nat2 was not expressed in the skin covering the hindbrain or the extremities of the limbs (Figure 4a ). Embryonic sectioning at E12.5 and E15.5 allowed a more detailed analysis of Nat2 expression. At E12.5, X-gal staining was evident throughout the neural tube, in the walls of the heart ventricles, the 0 external probe or (ii) digested with BglII and hybridised with a 3 0 internal probe. Arrows on the left give marker sizes and arrows on the right indicate restriction fragment sizes. Clones 2 and 3 were used subsequently. (c) PCR amplification for routine genotyping of Nat2 knockout mice. DNA extracted from tissue samples was PCR amplified with primers mNAT2-1, mNAT2-910 and Neo-T. The presence of the wild-type and knockout alleles results in PCR products of 910 and 500 bp, respectively. Arrows indicate PCR product sizes. M ¼ Invitrogen 1 kb Plus DNA ladder. +/+ ¼ Nat2*wild-type; +/ À ¼ Nat2*heterozygote; À/À ¼ Nat2*null. Key: ' ¼ mouse Nat2; ¼ mouse Nat1; & ¼ TAG 3 /IRES/lacZ/neo cassette; ¼ thymidine kinase (tk) negative selection cassette.
primary head vein, the roof of the hindbrain and future cerebral cortex, the lens vesicle, developing gut and umbilical cord. By E15.5, staining was also evident in the kidney, the primordia of the follicles of the vibrissae (snout region) and in the region surrounding the cartilage primordial of the limbs (Figure 4 and data not shown). The intensity of the X-gal staining is gene dose dependent, as shown by the relative intensity of the staining in the Nat2*À/À and Nat2*+/À embryos. Staining was never observed in Nat2*+/+ embryos, although more than 15 embryos were investigated.
DISCUSSION
We describe the successful generation of a Nat2*null mouse line. At a gross anatomical level, a lack of Nat2 does not interfere with embryonic development or animal longevity on either a pure 129/Ola or mixed 129/Ola Â C57Bl/6 and 129/Ola Â A/J genetic backgrounds. To date, there is only a single report in the literature of an individual totally lacking in activity for the human homologue, NAT1, encoded by the NAT1*15 allele, which results in an enzyme truncated at amino acid 187 and for which the phenotype was not reported. 27 While it is important to determine the effect of genetic background on the Nat2*null phenotype (and we are continuing to backcross onto C57Bl/6J and A/J strains), it appears that genetic background does not affect the phenotype.
The murine Nat2*null line has been characterised, and breeding data (Table 1) indicated no statistically significant bias in the inheritance of the Nat2*null allele. However, there is a trend towards a greater number of females among live-born offspring of intercrosses (Nat2*+/À male Â Nat2*+/ À female), approaching significance at the 5% level. This indicates a possible sexual bias in allelic inheritance and will be monitored as our breeding programme continues. Sexual bias in inheritance of the allele could result from hormonal imprinting of Nat expression 19 but larger cohorts are required, particularly at the embryo stage, as the trend towards sexual bias in allelic inheritance was not apparent prior to E15.5. It has not been possible to identify the Nat genotype of offspring which did not result in live births either through death in utero or still births which may be a contributing factor. Nat2 activity and protein levels within the mouse colonies are shown to be gene dose dependent. Activity measurements with anisidine conclusively demonstrate that there is no compensatory expression in the liver of Nat2*null animals of the other Nat isoforms. These measurements also allowed preliminary dissection of the relative contributions of the different Nat isozymes to the acetylating capacity of mouse liver. Anisidine is acetylated by all three murine Nat enzymes, 17, 22, 25 thus, these results indicate that the Nat2 isoform is responsible for the majority of Nacetylation activity in murine liver. This trend agrees with a recent report of Nat activities in different mouse strains, where total Nat-and Nat2-specific activities were compared in wild-type mice and mice that are slow Nat2 acetylators. 22 The Nat loci were predicted to be within 130 kb on mouse chromosome 8 at B3.1-3.3, 15 and recent genome analysis indicates that they are within 60 kb ( Figure 5 ). However, the construct within the Nat2 allele does not appear to alter the expression of the other Nat loci as determined from enzyme activity studies and the detection of protein from Western blots.
Nat2 expression, as reported using the lacZ expression cassette, confirmed previous immunohistochemical reports 21 of expression from E9.5. Expression is maintained throughout gestation and into adulthood. In addition, X-gal staining of whole-mount embryos showed almost ubiquitous Nat2 expression throughout embryonic skin, an observation that was not amenable to immunohistochemical techniques. The X-gal method will also be extremely useful in detecting Nat2 expression in embryos prior to E9.5 Assuming Mendelian ratios of allelic inheritance, the predicted ratio of Nat2 alleles among offspring is as follows: a 1 : 1 Nat2*+/+ : Nat2* +/À (Nat2* +/À male Â C57Bl/ 6J or A/J female); b 1 : 2 : 1 Nat2*+/+ : Nat2* +/À : Nat2*À/À (Nat2* +/À male Â Nat2* +/À female). w 2 values (and associated P-values), calculated assuming the Nat2* null allele is inherited in a Mendelian fashion, were as follows: . In all cases, inheritance of the transgene was determined by PCR. Where embryos were harvested before term, embryonic sex was determined by amplification of the Sry gene. 41 Observed numbers of male and female offspring and offspring of each genotype are given. Expected numbers of offspring, assuming Mendelian inheritance of the transgene, are given in parenthesis. NR= not relevant. Backcross: Nat2*+/À males were mated with either C57Bl/6J or A/J females. All pregnancies were allowed to go to term. Intercross: Nat2*+/À males were mated with Nat2*+/À females. Pregnancies were either allowed to proceed to term or offspring were harvested at either E9.5, E10.5, E11.5, E12.5, E13.5 or E15.5 following cervical dislocation of the mother. and these studies are underway. Although Nat2 is not essential for embryonic development, preliminary investigations that we have carried out indicate that Nat2 expression is upregulated in the neural tube from at least E8.5. An explanation for the widespread tissue distribution of Nat2 remains to be elucidated but it supports the hypothesis that Nat2 has an endogenous role other than the metabolism of xenobiotics. The inability of Nat2*À/À liver homogenates to acetylate the folate catabolite p-abaglu and the p-abaglu acetylation capabilities of Nat2*+/À liver at 50% that of Nat2*+/+ mice supports Nat2 as the enzyme responsible for this reaction in vivo. In view of the lack of phenotype, these results suggest either that Nat is not essential or that another enzyme (other than Nat1 or Nat3) plays a compensatory role in tissues other than the liver. There is evidence in the human placenta using a NATspecific inhibitor to suggest that such an enzyme exists. 13 However, in view of the activity measurements in knockout mice that we have carried out in the liver and also recently in the kidney, the latter explanation seems less likely.
Folate supplementation has been linked to the prevention of a number of developmental abnormalities including neural tube defects (NTDs) and cleft lip with or without cleft palate (CL/P), although the mechanism(s) of folate involvement is not clear. 28, 29 In addition, the action of 6-aminonicotinamide, a facial cleft causing teratogen, has been linked to the murine Nat locus 30 and there are suggested links between NAT polymorphisms and CL/P in infants of smoking mothers. 31 However, the nature of the link between NAT and developmental abnormalities is still unanswered. 31, 32 Interestingly, we have demonstrated that overexpression of human NAT1 in mice causes developmental abnormalities, 33 and therefore the relation between NAT and folate metabolism warrants further investigation.
There exists an extensive list of knockout animals for xenobiotic metabolising enzymes (reviewed in Gonzalez 34 ), the majority of which are phenotypically normal. Relatively little is known about the toxicological status of the developing embryo, which can potentially be exposed to xenobiotics via the placenta. 35 The expression status of drug metabolising enzymes in both the embryo and the placenta 36 could have developmental consequences as a result of maternal exposure to teratogens or carcinogens. Crossbreeding of our Nat2*null strain with a strain lacking in one of the cytochrome P450 isozymes, for example, Cyp1A2, 37 would produce animals lacking both a phase I and phase II drug metabolising enzyme and facilitate further understanding of the developmental importance of xenobiotic metabolism. Figure 2 Nat activity in mouse liver homogenates. Liver samples from Nat2*wild-type (+/+), Nat2*heterozygote (+/À) and Nat2*null (À/À) adult mice were homogenised and assayed for activity with specific substrates. (a) Time course of p-abaglu acetylation. Time is shown on the x-axis and nmol N-acetyl p-abaglu produced/mg protein on the y-axis. Activity in Nat2*wild-type (+/+), Nat2*heterozygote (+/À) and Nat2*null (À/À) liver homogenates is shown by filled circles, open circles and filled triangles, respectively. (b) Activity using p-aba and anisidine as substrate. Nat2 genotype is shown on the x-axis and specific activity (nmol arylamine Nacetylated/min/mg protein)7standard deviation of six homogenate samples of each genotype is given on the y-axis. Solid and hashed bars illustrate activity with p-aba and anisidine, respectively. 
MATERIALS AND METHODS
Unless otherwise stated, all chemicals were purchased from Sigma-Aldrich Co. Ltd. (Poole, Dorset, UK). All work involving animals was carried out according to the Animals (Scientific Procedures) Act 1986 and was subject to local ethical review.
Construction of Targeting Vectors and Targeted ES Cells
A mouse Nat2 replacement targeting vector was constructed using cloned 129/Ola genomic DNA from an E14 TG2a library. The targeting construct incorporated a TAG 3 /IRES/ lacZ/loxP/neo/loxP reporter/ablation cassette. 26 The reporter/ ablation cassette was inserted at a BglII site in the Nat2 coding region and an MC1-thymidine kinase dimer negative selection cassette 38 appended at the end of one of the homology arms (Figure 1a(i) ). The reporter/ablation cassette was used to generate a likely null allele of murine Nat2 by homologous recombination in ES cells. E14-TG2a-IV ES cells (129/Ola derived) cultured according to standard protocols 39 were electroporated with 100 mg targeted vector linearised at a NotI restriction site and selected in 160 mg/ ml G418 and 2.5 mM gancyclovir. Drug-resistant clones were screened by Southern blot analysis of EcoRI-digested genomic DNA using a hybridisation probe (800 bp EcoRV/SalI fragment) flanking and external to the 5 0 homology arm, which detects a 26 and a 22 kb fragment in wild and targeted alleles, respectively (Figure 1a (ii) and b(i)). Targeting was subsequently confirmed by digestion of genomic DNA with BglII and hybridisation with a 3' internal probe (1 kb, BglII/ EcoRV fragment), which detects a 3.6 and a 10.2 kb fragment in wildtype and targeted alleles, respectively (Figure 1a(iii) and b(ii)), and by a PCR strategy (Figure 1a(iv) and c. For experimental details see Routine Genotyping of Nat2 Knockout Mice.).
Chimera Generation Analysis and Breeding
Targeted ES cells were injected into C57Bl/6 blastocysts to generate chimeras according to standard protocols. 40 Resultant male chimeras were testcrossed with C57Bl/6 females and germline transmission confirmed in agouti coatcoloured offspring by Southern blot analysis (as above). To determine viability of mice homozygous for the null allele, testcross offspring, heterozygous for the null allele (Nat2*+/À), were intercrossed to generate wild-type (+/+), heterozygous (+/À) and homozygous (À/À) pups. The Nat2-deficient strains were maintained by backcrossing heterozygous males with C57Bl/6 females and A/J females at each generation. High transmitting chimeras were also testcrossed to 129/Ola female mice to obtain the null allele on a pure genetic background.
Routine Genotyping of Nat2 Knockout Mice For routine PCR-based genotyping, DNA was extracted from tissue discarded from ear clippings, taken for identification at weaning, and in the case of embryos, from the yolk sac. For tissue digestion, samples were digested for a minimum of 3 h at 551C in 200 ml lysis buffer (100 mM Tris-HCl pH 8.5, 5 mM EDTA, 0.2% SDS, 200 mM NaCl) containing 200 mg/ml proteinase K. Proteinase K was denatured by incubation at 801C for 15 min and undigested tissue was pelleted by centrifugation in a microfuge at 13 000 rpm, room temperature for 10 min. DNA was precipitated by the addition of an equal volume of isopropanol and spooled into 20 ml TE pH 8.0. The presence/absence of the targeted allele was determined using a PCR with primers mNAT2-1, mNAT2-910 and Neo-T. Amplification of the wild-type Nat2 allele (using mNAT2-1 and mNAT2-910 15 ) results in a product of 910 bp, whereas amplification of the Nat2* null allele (using mNat2-910 and Neo-T) (Neo-T sequence: 5 0 CATCGCCTTCTATCGCCTTCT3 0 , antisense, anneals in the neomycin cassette) results in a product of 500 bp ( Figure  1a (iv) and c). Under these PCR conditions, mNAT2-1 and mNAT2-910 were unable to amplify product from the Nat2*null allele because of the presence of the 5.2 kb replacement cassette. PCR was performed in a final volume of 50 ml using 2 ml DNA solution, with each primer at a final concentration of 1 pmol/ml and MgCl 2 at a final concentration of 1.5 mM. PCR conditions: initial denaturation at 941C for 5 min, denaturation at 941C for 30 s, annealing of primers at 561C for 30 s, elongation at 721C for 1 min, 35 cycles. Figure 3 Western blotting of liver homogenates with antisera specific for mouse Nat isozymes. Liver samples were homogenised, separated by SDS-PAGE and Western blotted using (a) primary antisera specific for mouse Nat2 (antiserum 195) or (b) primary antiserum, which recognises all mouse isozymes (antiserum 185). Liver homogenates were taken from Nat2*wild-type (+/+), Nat2*heterozygote (+/À) and Nat2*null (À/À) adult mice. Lanes 1, 2 and 3 contain 150, 75 and 37.5 lg, respectively, of liver homogenate from a Nat2*+/+ mouse. Lanes 4, 5 and 6 contain 150, 75 and 37.5 lg, respectively, of liver homogenate from a Nat2*+/À mouse. Lanes 7, 8 and 9 contain 150, 75 and 37.5 lg, respectively, of liver homogenate from a Nat2*À/À mouse. Arrows indicate molecular weights of protein markers (Amersham Pharmacia Biotech) run on the gel as a standard.
The sex of embryos was determined by PCR amplification of Sry according to a previously described protocol. 41 Briefly, the reaction included primer pairs for both Sry and myogenin that generate a male-specific band of 441 bp and an internal control band of 245 bp, respectively.
Protein Sample Preparation
Liver samples were dissected from adult animals immediately following cervical dislocation and snap frozen in liquid nitrogen. Samples were homogenised and prepared for Western blotting or enzymatic activity assay as described previously. 10 Figure 4 X-gal staining as a reporter for Nat2 expression. Embryos were harvested from pregnant Nat2*+/À females that had been mated with Nat2*+/À males and stained for b-galactosidase activity using X-gal as substrate. Following staining, embryos were either (a) wholemount photographed or (b-h) embedded in wax and 10 lM sections cut on a microtome. Representative samples of X-gal staining (blue colour) in Nat2*null embryos (a, b, d, f, h) and a lack of staining in Nat2*+/+ embryos (a, c, e, g), as controls are shown in (a) whole embryos at E12.5, (b, c) the region surrounding the developing eye and lens vesicle at E12.5 (the eye is indicated by an arrow), (d, e) the wall of the heart ventricles at E12.5 (staining indicated by arrows), (f, g) primordia of the follicles of the vibrissae (snout region) at E15.5 (staining indicated by arrows) and (h) the region surrounding the cartilage primordia in the lower limb at E15.5 (staining indicated by arrows). +/ + ¼ Nat2*wild-type, +/À ¼ Nat2*heterozygote and À/À ¼ Nat2*null. Original magnification: (a) Â 6; (b-g) Â 20; (h) Â 12.5.
Antisera Production and Western Blotting
Protein from liver homogenates was blotted following SDS-PAGE and the filters probed using rabbit antisera specific either for the murine Nat2 isozyme (antiserum 195) 21 or all three murine Nat isozymes (antiserum 185). Antiserum 185, raised against the human NAT 'active site peptide' (sequence RRNRGGWCLQVN), conjugated via cysteine to bovine serum albumin for immunisation, 42 recognises all mammalian NAT isozymes.
Enzymatic Activity Measurements
Liver homogenates were assayed for their ability to acetylate p-aba, para-anisidine and p-abaglu using the colorimetric method described previously. 43 Before assay, the homogenate was diluted in 20 mM Tris-HCl pH 7.5, 1 mM DTT, to give a linear initial rate. The final concentration of the substrates was: p-aba, 75 mM; anisidine, 75 mM; p-abaglu, 60 mM. Pools of homogenates from six different livers were made for use as standards. 44 Staining of Embryos for b-Galactosidase Activity Nat2*+/À males were housed with Nat2*+/À females overnight and mating was confirmed by the presence of a copulation plug the next morning. Noon on the day of finding a copulation plug was designated as embryonic day (E) 0.5. Pregnant females were killed by cervical dislocation on E9.5, E10.5, E11.5, E12.5 and E15.5, and embryos explanted into ice-cold phosphate-buffered saline pH 7.4. Extraembryonic membranes were removed, a portion of which was retained for subsequent genotyping analysis. Embryos were fixed in ice-cold 0.2% glutaraldehyde solution (in 0.1 M phosphate buffer pH 7.3, containing 5 mM EGTA, 2 mM MgCl 2 ) and assayed for b-galactosidase activity using X-gal as previously described. 45 To observe X-gal staining at the cellular level, embryos were dehydrated through alcohol (70%, 90%, 95%, 100% ethanol close parenthesis) to xylene and embedded in wax. Sections of 10 mM were cut on a microtome.
